American Oncology Network, Inc. Share Price
Equities
AONC
US0287191029
Healthcare Facilities & Services
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
3.5 USD | +0.86% | -5.66% | -40.68% |
15/05 | Earnings Flash (AONC) AMERICAN ONCOLOGY NETWORK Posts Q1 Revenue $364.3M | MT |
03/05 | American Oncology Network Announces Chief Financial Officer Changes | CI |
Sales 2022 | 1.15B 95.94B | Sales 2023 | 1.28B 107B | Capitalization | 56.35M 4.7B |
---|---|---|---|---|---|
Net income 2022 | 2M 167M | Net income 2023 | -5M -417M | EV / Sales 2022 | - |
Net Debt 2022 | 91.97 7.68K | Net Debt 2023 | 68.94 5.75K | EV / Sales 2023 | 0.04 x |
P/E ratio 2022 * |
-
| P/E ratio 2023 |
-4.32
x | Employees | 1,525 |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 57.31% |
1 day | +0.86% | ||
1 week | -5.66% | ||
Current month | -8.38% | ||
1 month | -31.64% | ||
3 months | -39.24% | ||
6 months | -41.86% | ||
Current year | -40.68% |
Managers | Title | Age | Since |
---|---|---|---|
Todd Schonherz
CEO | Chief Executive Officer | 54 | 20/23/20 |
David Gould
DFI | Director of Finance/CFO | 53 | 20/23/20 |
Stephen Divers
CTO | Chief Tech/Sci/R&D Officer | 51 | 20/23/20 |
Members of the board | Title | Age | Since |
---|---|---|---|
Bradley Fluegel
BRD | Director/Board Member | 62 | 20/23/20 |
James Stith
BRD | Director/Board Member | 40 | 20/23/20 |
Todd Schonherz
CEO | Chief Executive Officer | 54 | 20/23/20 |
Date | Price | Change | Volume |
---|---|---|---|
15/24/15 | 3.5 | +0.86% | 25,675 |
14/24/14 | 3.47 | +0.29% | 20,432 |
13/24/13 | 3.46 | -2.54% | 4,273 |
10/24/10 | 3.55 | -2.94% | 5,914 |
09/24/09 | 3.658 | -1.42% | 8,963 |
End-of-day quote Nasdaq, May 15, 2024
More quotes1st Jan change | Capi. | |
---|---|---|
-40.68% | 37.12M | |
+20.79% | 85.64B | |
-28.75% | 70.63B | |
+3.38% | 27.05B | |
-6.19% | 17.97B | |
+1.78% | 17.58B | |
+2.10% | 15.64B | |
+7.06% | 13.55B | |
+10.06% | 13.41B | |
+71.31% | 13.18B |
- Stock Market
- Equities
- AONC Stock